DCOY

← Markets

DCOYDecoy Therapeutics Inc.

Discussion

Nothing said here yet.

to join the conversation.

—

Mon, Aug 3
8:00 AMYahooDecoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform
Mon, Jul 27
8:00 AMYahooDecoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV™ Platform into High Consequence Global Health Threats
Wed, Jul 15
8:24 AMYahooDecoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors
Mon, Jun 29
10:41 AMstocktwits.comDCOY Stock Nearly Doubled In Value Today – What’s Driving This Mega Rally?
Fri, Jun 26
7:11 PMYahooDecoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
Mon, Jun 8
7:00 AMYahooDecoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London
Wed, Jun 3
7:00 AMYahooDecoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors
Mon, Jun 1
6:00 AMYahooDecoy Therapeutics Partners with hVIVO to Advance Lead D-MAV™ Candidate into the Clinic
Tue, May 26
7:15 AMYahooDecoy Therapeutics Names Brad Pentelute, MIT Professor of Chemistry, as Chair of Scientific Advisory Board
Mon, Apr 27
7:45 AMYahooDecoy Therapeutics to Present at Two Peptide Therapeutics Conferences in Boston
Thu, Apr 9
7:36 AMYahooDecoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline
Mon, Apr 6
8:15 AMYahooDecoy Therapeutics to Participate in Virtual Investor Closing Bell Event Highlighting Business Outlook for 2026